Retinoid Signaling Is Required for Chondrocyte Maturation and Endochondral Bone Formation during Limb Skeletogenesis  by Koyama, Eiki et al.
b
c
c
c
n
c
a
R
a
e
e
m
b
d
d
i
Developmental Biology 208, 375–391 (1999)
Article ID dbio.1999.9207, available online at http://www.idealibrary.com onRetinoid Signaling Is Required for Chondrocyte
Maturation and Endochondral Bone Formation
during Limb Skeletogenesis
Eiki Koyama,* Eleanor B. Golden,* Thorsten Kirsch,*
Sherrill L. Adams,† Roshantha A. S. Chandraratna,‡
Jean-Jacques Michaille,§ and Maurizio Pacifici*
*Department of Anatomy and Histology and †Department of Biochemistry, School of Dental
Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104; ‡Allergan
Pharmaceuticals, Irvine, California 97213; and §Institut Albert Bonniot, Faculte de Medecine,
Universite J. Fourier-Grenoble 1, 38706 LaTronche Cedex, France
Retinoids have long been known to influence skeletogenesis but the specific roles played by these effectors and their nuclear
receptors remain unclear. Thus, it is not known whether endogenous retinoids are present in developing skeletal elements,
whether expression of the retinoic acid receptor (RAR) genes a, b, and g changes during chondrocyte maturation, or how
interference with retinoid signaling affects skeletogenesis. We found that immature chondrocytes present in stage 27 (Day
5.5) chick embryo humerus exhibited low and diffuse expression of RARa and g, while RARb expression was strong in
perichondrium. Emergence of hypertrophic chondrocytes in Day 8–10 embryo limbs was accompanied by a marked and
selective up-regulation of RARg gene expression. The RARg-rich type X collagen-expressing hypertrophic chondrocytes lay
elow metaphyseal prehypertrophic chondrocytes expressing Indian hedgehog (Ihh) and were followed by mineralizing
hondrocytes undergoing endochondral ossification. Bioassays revealed that cartilaginous elements in Day 5.5, 8.5, and 10
hick embryo limbs all contained endogenous retinoids; strikingly, the perichondrial tissues surrounding the cartilages
ontained very large amounts of retinoids. Implantation of beads filled with retinoid antagonist Ro 41-5253 or AGN 193109
ear the humeral anlagens in stage 21 (Day 3.5) or stage 27 chick embryos severely affected humerus development. In
omparison to their normal counterparts, antagonist-treated humeri in Day 8.5–10 chick embryos were significantly shorter
nd abnormally bent; their diaphyseal chondrocytes had remained prehypertrophic Ihh-expressing cells, did not express
ARg, and were not undergoing endochondral ossification. Interestingly, formation of an intramembranous bony collar
round the diaphysis was not affected by antagonist treatment. Using chondrocyte cultures, we found that the antagonists
ffectively interfered with the ability of all-trans-retinoic acid to induce terminal cell maturation. The results provide clear
vidence that retinoid-dependent and RAR-mediated mechanisms are required for completion of the chondrocyte
aturation process and endochondral ossification in the developing limb. These mechanisms may be positively influenced
y cooperative interactions between the chondrocytes and their retinoid-rich perichondrial tissues. © 1999 Academic Press
Key Words: retinoids; retinoic acid receptors; retinoid antagonists; Indian hedgehog; type X collagen; cartilageevelopment; limb skeletogenesis; perichondrium.
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Studies conducted over 4 decades ago first provided
evidence that retinoids play important roles in skeletal
development (Mellanby, 1944; Wolbach and Hegsted, 1952,
1953; Wilson et al., 1953). Those studies showed that both
ietary hyper- and hypovitaminosis A lead to disturbances
n the normal patterns of chondrocyte maturation in long
d
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All rights of reproduction in any form reserved.one growth plates and in the rates and degree of substitu-
ion of mineralized hypertrophic cartilage with bone in
rowing animals (see Howell and Thompson, 1967; Ornoy
nd Zusman, 1983; Gudas et al., 1994 and references
herein). For example, in vitamin A-deficient avians Wol-
ach and Hegsted (1952, 1953) observed a lack of a clear
emarcation of the proliferative zone in growth cartilage, an
ncrease in extracellular matrix, and a broad zone of en-
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376 Koyama et al.larged chondrocytes with undermineralized matrix, while
in vitamin A-deficient guinea pigs Harris et al. (1978)
bserved bone overgrowth and reduction in marrow cavity
ith moderate changes in growth cartilage.
A connection between retinoids and skeletal develop-
ent has been reinforced by more recent studies demon-
trating that members of the retinoid nuclear receptor gene
amily are expressed during the early phases of skeletogen-
sis and that inactivation of these genes leads to skeletal
efects. The retinoid nuclear receptors comprise two sub-
amilies, the retinoic acid (RA) receptors RARa, b, and g
and the retinoid X receptors RXRa, b, and g. These recep-
tors act as ligand-dependent transcription factors, form
heterodimers, bind to specific responsive sequences, and
modulate gene expression (reviewed in Mangelsdorf et al.,
1994; Chambon, 1994). During limb skeletal development,
RARa and RARg are broadly expressed at very early stages
nd display overlapping patterns while RARb is expressed
in the proximal mesenchyme; with further development,
RARg becomes expressed preferentially in both prechon-
rogenic mesenchymal condensations and newly differen-
iated chondrocytes, while RARa remains diffuse and
ARb expression becomes restricted to perichondrial cells
and interdigit zones (Dolle et al., 1989; Ruberte et al., 1990;
endelsohn et al., 1991; Smith et al., 1995). In comparison
o the RARs, expression of the RXRs is broad and uniform
hroughout the mesenchyme during limb development
Dolle et al., 1994), a possible reflection of the fact that
XRs serve as heterodimer partners for both RARs and
ther nuclear receptors (Mangelsdorf et al., 1994). Gene
nactivation studies have shown that inactivation of a
ingle RAR family member usually causes minor to no
keletal defects, whereas double gene inactivations, such as
ouble null mutants of RARa and RARg, produce serious
keletal abnormalities (Li et al., 1993; Lohnes et al., 1993,
994; Mendelsohn et al., 1994). These studies have sug-
gested that inactivation of a single RAR gene can be
compensated for by another family member but inactiva-
tion of two RARs cannot and does not permit normal limb
development and skeletogenesis.
While the above in vivo studies have clearly established a
need for retinoids and retinoid-dependent mechanisms in
normal skeletal development, the specific roles played by
these powerful molecules and their nuclear receptors re-
main unclear. This is particularly so with regard to the
complex multistage process of chondrocyte maturation
during endochondral ossification (Pacifici, 1995). Thus, we
do not know whether resting, proliferating, prehypertro-
phic, hypertrophic, and/or mineralizing chondrocytes in
vivo are the target of retinoid action and what the nature of
this biological action may be. Likewise, we do not know
whether and which retinoid receptors are expressed at each
stage of chondrocyte maturation or whether and at which
stage chondrocytes contain endogenous retinoids. To ad-
dress some of these questions, we conducted a series of
studies over the past few years to analyze the effects of
retinoids on the development and behavior of chondrocytes
Copyright © 1999 by Academic Press. All rightisolated from chick embryo cartilages and grown in culture
(Pacifici et al., 1991; Iwamoto et al., 1993a, 1994; Shapiro et
al., 1994). One particularly interesting finding was that
prehypertrophic and early hypertrophic chondrocytes iso-
lated from chick embryo sternum or tibia appeared unable
to advance in maturation when reared under control culture
conditions, but did so when provided with exogenous
natural retinoids such as all-trans-RA (Oettinger and
Pacifici, 1990; Iwamoto et al., 1993b) or 9-cis-RA (our
unpublished observations) at physiological doses of 1 to 50
nM. For example, newly emerged hypertrophic chondro-
cytes isolated from the cephalic portion of Day 17 chick
embryo sternum were able to maintain expression of early
maturation markers, such as type X collagen, over time in
culture; however, they required treatment with all-
trans-RA to up-regulate expression of genes characteristic
of the terminal posthypertrophic stage of maturation, in-
cluding alkaline phosphatase, osteonectin, osteopontin, and
type I collagen, and to deposit apatitic crystals in their
surrounding extracellular matrix (Iwamoto et al., 1993b,
1994; Kirsch et al., 1997). In sum, it appears that the
chondrocyte maturation process, proper sequential modu-
lation of maturation-related genes, and ultimate deposition
of a mineralized cartilage matrix all require retinoid-
mediated biological action. To determine whether retinoids
and their nuclear receptors play a similar role in vivo, we
ave analyzed in the present study whether there are
hanges in RAR gene expression during chondrocyte matu-
ation in vivo, whether maturing chondrocytes contain
ndogenous retinoids, and whether interference with the
iological action of these retinoids and RAR(s) by treatment
ith retinoid antagonists (Keidel et al., 1994; Klein et al.,
1996) alters chondrocyte maturation and skeletogenesis in
the developing limb.
MATERIALS AND METHODS
In Situ Hybridization
This procedure was carried out as described previously (Noji et
al., 1990; Koyama et al., 1995). Briefly, chick embryos or embryo
parts were fixed with 4% paraformaldehyde for 4 h or overnight,
mbedded in paraffin, and sectioned. The 5-mm-thick sections were
retreated with 1 mg/ml proteinase K (Sigma, St. Louis, MO) in 50
mM Tris, 5 mM EDTA, pH 7.5, at room temperature for 1 min;
immediately postfixed in 4% paraformaldehyde buffer for 10 min;
and then washed twice in PBS containing 2 mg/ml glycine for 10
min/wash. Sections were treated for 15 min with a freshly prepared
solution of 0.25% acetic anhydride in triethanolamine buffer.
Sections were hybridized with 35S-labeled antisense or sense ribo-
probes (approximately 1 3 106 dpm/section) at 50°C for 16 h. After
hybridization, slides were washed three times with 23 SSC con-
taining 50% formamide at 50°C for 20 min/wash, treated with 20
mg/ml RNase A for 30 min at 37°C, and finally washed three times
with 0.13 SSC at 50°C for 10 min/wash. Sections were coated with
Kodak NTB3 emulsion diluted 1:1 with water, exposed for 7 days,
and developed with Kodak D19 for 3 min at 20°C. After staining
with hematoxylin and eosin, slides were analyzed with a Nikon
microscope using bright- and dark-field optics.
s of reproduction in any form reserved.
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377Retinoids, RARs, and Limb Skeletal DevelopmentThe chick cDNA probes used were the 1.6-kb RARa and 0.9-kb
RARb clones encompassing the ligand binding domain (Noji et al.,
1991); a 0.16-kb RARg subclone (nucleotides 444–607) prepared
from full-length RARg2 (Michaille et al., 1994) and encoding a
ortion of domain C; a 0.56-kb Ihh clone encoding part of the
-terminal domain (Vortkamp et al., 1996); the type I collagen
GEM821, a 0.82-kb clone from the 39 end of type I collagen
ubunit a2(I) (Bennett et al., 1989); the type II collagen clone pDLr2
(Leboy et al., 1989), a 0.8-kb clone from the 39 region of type II
collagen (Young et al., 1984); the 0.197-kb type X collagen clone
pDLr10 (Leboy et al., 1989); and the 1.1-kb clone pMMPP2 con-
taining the full coding sequence of osteopontin (Moore et al., 1991).
Antagonist Treatment
The RAR antagonists used were Ro 41-5253 from Hoffmann–La
Roche (Basel, Switzerland) and AGN 193109 from Allergan Phar-
maceuticals (Irvine, CA). Ro 41-5253 exerts antagonistic effects on
all RAR isoforms but preferentially on RARa (IC50 5 60 nM); its
IC50 for RARg is 3300 nM (Apfel et al., 1992; Keidel et al., 1994).
GN 193109 inhibits equally well RARa, b, and g and has a nearly
00-fold lower IC50 for RARg (5 6 1 nM) (Klein et al., 1996)
compared to Ro 41-5253. AG1-X2 ion-exchange beads 200–400 mm
in diameter were soaked for 1 h in solution of Ro 41-5253 or AGN
193109 at concentrations ranging from 3.5 mM to 3.5 mM. This
range of concentrations was based on previous studies; for example,
a concentration of about 5 mM was recently used to study the
effects of retinoid antagonists on development of the zone of
polarizing activity in chick limbs (Lu et al., 1997). Antagonist
solutions were prepared in DMSO and used under yellow light
conditions; control beads were soaked in DMSO alone. Beads were
then dipped very briefly in phenol red-containing saline (HBSS) so
that they were more readily visible during implantation.
Antagonist-containing or control beads were implanted in the
wing bud of stage 21–22 (Day 3–3.5) or stage 27–28 (Day 5.5) chick
embryos (Hamburger and Hamilton, 1951); contralateral wing bud
served as control. A small window was opened in the egg shell and
a small incision was made on the anterodorsal proximal portion of
the bud. One bead or several beads were then placed in the vicinity
of the prospective humerus as specified below, and eggs were sealed
and returned to the incubator. On the day of analysis, embryos
were sacrificed by decapitation, and control and operated wings
were examined by microscopy, using a Nikon SMZ-U dissecting
photomicroscope, and humerus length was measured micrometri-
cally. Because length of control humeri varied slightly from embryo
to embryo, possibly reflecting slight differences in age, humeri
were considered affected by antagonist treatment only if their
length was shortened at least 25% over control value. Companion
control and antagonist-treated limbs were processed for histology
and in situ hybridization using tissue sections.
Chondrocyte Cultures
Cell populations rich in prehypertrophic and early hypertrophic
chondrocytes were isolated from the cephalic core region of Day
17–18 chick embryo sterna, while immature chondrocytes were
isolated from the caudal sternal region (Gibson and Flint, 1985;
Pacifici et al., 1991; Iwamoto et al., 1993b). The dissected cephalic and
caudal tissues were incubated for 1 h at 37°C in saline containing
0.1% type 1-S collagenase (Sigma); the cells released after this incu-
bation were discarded as they consisted mainly of perichondrial and
blood cells. The remaining tissue was incubated in a fresh mixture of 1
Copyright © 1999 by Academic Press. All right0.25% trypsin and 0.1% collagenase for 3 h at which point it was
completely digested. The freshly isolated chondrocytes were plated at
a density of 2 3 105 cells/well in 12-well plates, 1 3 106 cells/60-mm
dish, or 3 3 106 cells/100-mm dish. The cephalic core chondrocytes
were grown continuously, without subculturing, for 2 to 3 weeks in
monolayer; during the first 2 days, cultures received 4 U/ml of
testicular hyaluronidase to minimize cell detachment (Leboy et al.,
1989), and cultures became confluent by 2 weeks. The caudal imma-
ture chondrocytes were first grown for 5 days at which point floating
immature chondrocytes were separated from attached contaminating
fibroblastic cells. The floating cells were trypsinized and replated in
secondary cultures in the presence of hyaluronidase to increase cell
attachment. Cultures were fed every other day with Dulbecco’s
modified high-glucose Eagle’s medium (GIBCO BRL, Gaithersburg,
MD) containing 10% defined fetal calf serum (Hyclone, Logan, UT), 2
mM L-glutamine, and 50 U/ml penicillin and streptomycin (Pacifici et
l., 1991). When indicated, cultures were treated with all-trans-RA
Sigma) or combinations of all-trans-RA and Ro 41-5253. Stock
olutions of these retinoids were prepared in DMSO and were diluted
nto working solutions in 95% ethanol; control dishes received an
quivalent amount of vehicle without retinoids. To analyze mineral-
zation, cephalic sternal control and retinoid-treated cultures were
upplemented with 3 mM b-glycerophosphate to serve as a phosphate
ource. During these various regimens, medium was changed daily.
o localize calcium deposits, the cell layers were stained with 0.5%
lizarin red S solution, pH 4.0, for 5 min at room temperature. In
xperiments in which cultures were treated for 2, 4, or 6 days, retinoid
reatments were initiated so that all cultures (including control
ultures) were harvested simultaneously.
RNA Isolation and Analysis
Whole cellular RNA isolated by the guanidine isothiocynate
method (Chomczynski and Sacchi, 1987) was denatured by glyox-
alation, electrophoresed on 1% agarose gels at 10 or 30 mg/lane, and
transferred to Hybond-N membranes by capillary blotting, as
described previously (Oettinger and Pacifici, 1990; Iwamoto et al.,
1993a). Blots were stained with 0.04% methylene blue to verify
that each sample had been transferred efficiently. Blots were
hybridized for 16 h to 32P-labeled DNA probes at a concentration of
.5 3 106 dpm/ml of hybridization solution containing 50%
ormamide, 1.53 SSPE, 500 mg/ml sheared denatured salmon sperm
NA, 100 mg/ml tRNA, 0.5% (w/v) dry milk, and 1% SDS. The
cDNA probes used were the same as those used for in situ
hybridization. Hybridization temperature was 55°C for RARg and
Pase and 60°C for type X collagen. After hybridization, blots were
insed several times at room temperature with 23 SSC and 0.5%
DS; a final high-stringency rinse was with 0.13 SSC and 0.5%
SDS at 70°C. Blots were exposed to Kodak BioMax X-ray films at
270°C.
Retinoid Analysis
Semiquantitative analysis of endogenous retinoid levels in em-
bryonic tissues was carried out using a sensitive in vitro reporter
ssay (Wagner et al., 1992; McCaffery et al., 1992). The assay
onsists of F9 teratocarcinoma cell line stably transfected with a
eporter construct which contains a 64-bp retinoic acid-response
lement (RARE) from the human RARb gene (de The et al., 1990)
placed immediately upstream of the Escherichi coli lacZ gene. The
F9 cell line constitutively expresses RARa, b, and g (Zelent et al.,
989), which confer retinoid responsivity to the stably transfected
s of reproduction in any form reserved.
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378 Koyama et al.construct. Cells were maintained on gelatin-coated dishes in modi-
fied L15 CO2 tissue culture medium (Specialty Media, Lavallette,
NJ) supplemented with 20% fetal calf serum and 0.8 mg/ml G418
(complete medium) and were used when 80–90% confluent. Under
this culture condition, the reporter cells have been shown to be
very sensitive to exogenous all-trans-RA treatment at concentra-
tions as low as 0.01 nM (Wagner et al., 1992). We have confirmed
these findings (see below) and have also found that the cells
respond to exogenous 9-cis-RA, a ligand for both RXRs and RARs
(Levin et al., 1992; Mangelsdorf et al., 1994), with a 10-fold lower
sensitivity than that displayed in response to all-trans-RA treat-
ment (our unpublished observations).
To prepare tissue extracts, tissues were surgically isolated from
Day 5.5, Day 8, and Day 10 chick embryos and included the
metaphyseal–diaphyseal portion of cartilaginous humerus and
tibia from which adherent perichondral tissues were carefully
removed, liver, brain, skin, eye, and heart. During isolation, all
tissues were kept in saline on ice under yellow safety light
conditions. About 200 mg of each tissue or organ was then
homogenized with a Polytron in 0.9 ml of L15 complete medium at
4°C and samples were then quick-frozen in dry ice for complete cell
disruption. Samples were thawed in iced water and were incubated
at 4°C for 1 h to extract retinoids. Extracts were centrifuged at
13,000g for 15 min at 4°C; the resulting supernatants were care-
fully separated from the pellet and were added directly to semicon-
fluent cultures of F9 reporter cells grown in 22-mm multiwell
plates (0.4 ml/well). Cultures were reincubated for 24 h and were
then processed for histochemical detection of b-galactosidase ac-
ivity (Lim and Chae, 1989). To confirm that b-galactosidase
ctivity was proportional to retinoid concentration, parallel cul-
ures of semiconfluent F9 cell cultures were treated with known
mounts of all-trans-RA ranging from 1 fM to 2 mM (from 1003
tock solutions in 95% ethanol), incubated for 24 h, and then
rocessed for quantitative analysis of b-galactosidase activity.
Briefly, cultures were fixed with 0.1% glutaraldehyde in 0.1 M
phosphate buffer, pH 7.0, for 15 min at room temperature. After
being rinsed with PBS, cultures were stained with a solution of
0.2% X-Gal in phosphate buffer for 16 h at 37°C. After being rinsed
again, cultures were extracted with 0.2 ml of DMSO and absor-
bance of the extracted material was determined at 655 nm using a
Perkin–Elmer spectrophotometer. Under these conditions, the F9
cells exhibited a linear increase in b-galactosidase activity between
1 nM and 0.5 mM all-trans-RA.
RESULTS
RAR Gene Expression during Skeletogenesis
In a first set of experiments, we determined the expres-
sion patterns of RARa, b, and g at different stages of chick
imb skeletogenesis. Longitudinal serial sections of limb
keletal elements were processed for in situ hybridization
sing 35S-labeled antisense riboprobes encoding chick
ARa, b, or g; as controls, sections were hybridized with
radiolabeled sense probes. When we examined early newly
emerged skeletal elements, such as the stage 27–28 (Day
5.5) chick embryo humerus, which contains only immature
chondrocytes and does not yet display growth plates (Figs.
1A, 1D, and 1G), we found that the gene expression levels of
RARa and g were low and diffuse (Figs. 1B and 1H); the level
of hybridization signal within the newly formed cartilagi-
Copyright © 1999 by Academic Press. All rightnous tissue was somewhat lower than that detected in the
surrounding mesenchymal and connective tissues. In con-
trast to the diffuse nondescript patterns of RARa and g,
gene expression of RARb was distinct and quite pronounced
in the perichondrial tissue, particularly along the incipient
diaphysis (Fig. 1E, arrow), though it was very low in the
cartilaginous tissue itself. Hybridization with sense RAR
probes yielded barely detectable signal (Figs. 1C and 1I). The
overall cartilaginous tissue was delineated by hybridization
with type II collagen antisense probe (Fig. 1F).
Between Days 8 and 10 of limb development, the long
bone cartilaginous models acquire more definitive morpho-
logical characteristics and organization. They display pro-
spective articular chondrocytes (ac) at their eiphyseal ends
FIG. 1. In situ hybridization analysis of RAR gene expression in
stage 27–28 (Day 5.5) chick embryo cartilaginous humerus. Longi-
tudinal serial sections were processed for hybridization using
35S-labeled antisense riboprobes encoding chick RARa (A and B),
ARb (D and E), or RARg (G and H). Arrow in E points to strong
ARb expression in perichondrium. Radiolabeled sense probes
S-RARa and S-RARg) elicited barely detectable levels of diffuse
ignal (C and I). Cartilaginous tissue was delineated by hybridiza-
ion with an antisense type II collagen riboprobe (F). Bar, 175 mm.and long growth plates with well-defined proliferative (pz),
postproliferative–prehypertrophic (phz), and hypertrophic
s of reproduction in any form reserved.
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379Retinoids, RARs, and Limb Skeletal Development(hz) zones occupying the metaphysis and diaphysis (Fig.
2A); in addition, the diaphysis begins the process of endo-
chondral ossification and is surrounded by an intramembra-
nous bony collar (Fell, 1925; Scott-Savage and Hall, 1979;
Osdoby and Caplan, 1981; Koyama et al., 1995). In situ
hybridization on serial sections of Day 10 chick embryo
wing showed that while RARa gene expression remained
ow and diffuse throughout the cartilaginous tissue (Fig. 2B)
nd RARb expression was still strong in perichondrium (not
shown), RARg expression was markedly up-regulated in the
ypertrophic zone of growth plate (Fig. 2C, arrow). Hybrid-
zation with a probe encoding type X collagen, a marker of
ypertrophic chondrocytes (Gibson and Flint, 1985), con-
rmed that there was a significant similarity between the
FIG. 2. In situ hybridization analysis of gene expression in Day 10
were processed for hybridization with 35S-labeled antisense ribop
steopontin (E), Ihh (F), type II collagen (G), or type I collagen (H)
lna’s disphysis (C, arrow) and proximal phalange (J, double arrow)
in medial and distal phalanges (J, arrow and arrowhead, respectiv
obvious and numerous at the periphery of the diaphysis (I, double a
the diaphysis (J, double arrow). ac, pz, phz, and hz in A, articular
respectively; pp, mp, and dp in I, proximal, medial and distal phalopographical distribution of type X collagen transcripts
nd RARg transcripts, though the increase in RARg tran-
Copyright © 1999 by Academic Press. All rightcripts slightly preceded that in type X collagen transcripts
Figs. 2C and 2D, arrows). Analysis of other markers re-
ealed that the RARg- and type X collagen-rich chondro-
cytes were preceded in the growth plate by prehypertrophic
chondrocytes expressing the morphogenetic factor Indian
hedgehog (Ihh) (Bitgood and McMahon, 1995; Koyama et
al., 1996a; Vortkamp et al., 1996) (Fig. 2F) and were fol-
lowed by mineralizing posthypertrophic chondrocytes un-
dergoing endochondral ossification and expressing late
maturation markers such as osteopontin (Fig. 2E, arrow)
(Iwamoto et al., 1993b). Osteopontin expression was also
detectable in the developing bony collar surrounding the
diaphysis and metaphysis (Fig. 2E, arrowheads). As ex-
pected, type II collagen gene expression was strong through-
embryo ulna (A–H) and digits (I and J). Longitudinal serial sections
encoding chick RARa (B), RARg (C and J), type X collagen (D),
e the strong expression of RARg in hypertrophic chondrocytes in
the lower number of RARg-expressing hypertrophic chondrocytes
note also that while hypertrophic chondrocytes are much more
) than toward the center, RARg transcripts are present throughout
, proliferative zone, prehypertrophic zone and hypertrophic zone,
, respectively. Bar, 185 mm.chick
robes
. Not
and
ely);
rrowsout most of the cartilaginous tissue but was markedly
down-regulated in the mineralizing and endochondral ossi-
s of reproduction in any form reserved.
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380 Koyama et al.fication zones (Fig. 2G, arrow) (Iyama et al., 1991), while
type I collagen RNA was confined to the bony collar,
perichondrial tissue, and other surrounding connective tis-
sues (Fig. 2H, arrowheads). Similar results were obtained
with Day 8.5 (stage 35) embryos (see below).
The relationship between increased RARg expression and
mergence of hypertrophic chondrocytes was further ana-
yzed in the digit area of Day 10 limbs, which contains short
keletal elements at different stages of development along
he proximal-to-distal axis in close proximity to each other.
ndeed, we found that the developmentally older proximal
halangeal (pp) elements contained abundant RARg tran-
cripts and numerous hypertrophic chondrocytes in the
iaphysis (Figs. 2I and 2J, double arrow), whereas the
evelopmentally younger medial phalange (mp) contained
ewer hypertrophic cells and lower amounts of RARg tran-
scripts (Figs. 2I and 2J, arrow) and the even younger distal
phalange (dp) contained neither (Figs. 2I and 2J, arrowhead).
Closer inspection of the diaphyseal region of the proximal
phalange revealed that, whereas the RARg transcripts were
present throughout the diaphysis (Fig. 2J, double arrow), the
hypertrophic chondrocytes were not; these cells were much
more obvious and numerous at the periphery of the diaphy-
sis than at its center (Fig. 2I, double arrow).
Taken together, the above data indicate that the RARs
display differential patterns of gene expression during limb
chondrocyte maturation and skeletogenesis; in particular,
while RARa expression remains broad and diffuse, RARg
expression is selectively up-regulated just before the chon-
drocytes become fully hypertrophic and remains high in the
hypertrophic cells. The data also indicate that the first
hypertrophic chondrocytes form at the periphery of carti-
laginous elements.
Retinoid Bioassays
Previous studies showed that early stage 20–21 chick
wing buds contain endogenous retinoids which are probably
involved in patterning of prechondrogenic mesenchymal
condensations (Eichele and Thaller, 1987; Thaller and
Eichele, 1990). Thus, we determined next whether the
cartilaginous skeletal elements present in limbs at later
stages of development also contain endogenous retinoids. If
so, the retinoids could obviously serve as ligands for the
RARs expressed at those stages; in addition, they could
have a direct or indirect role in regulating RAR gene
expression itself (Mangelsdorf et al., 1994). As an approach,
e used a sensitive bioassay that was previously used to
stimate endogenous retinoid levels in other developing
issues and organs in chick and mouse embryos (Wagner et
l., 1992; McCaffery et al., 1992). This bioassay utilizes a F9
eratocarcinoma cell line stably transfected with a retinoid-
ensitive RARE/b-galactosidase reporter construct.
We microsurgically isolated the entire cartilaginous hu-
merus from Day 5.5 (stage 27–28) embryos and the
metaphyseal–diaphyseal portion of humerus from Day 8.5
and 10 chick embryos; we then carefully separated the
Copyright © 1999 by Academic Press. All rightcartilaginous tissue from the surrounding perichondrial
tissues and processed the cartilaginous tissue for retinoid
analysis. For comparison, we processed for analysis the
perichondrial tissues themselves as well as liver, brain, eye,
and skin from the same Day 5.5, 8.5, and 10 embryos.
Perichondrial tissues from Day 5.5 embryos, however, were
excluded from analysis because they could not be obtained
in sufficient quantities given the small size of the embryos.
One hundred to 200 mg of each tissue or organ was
suspended in fresh complete culture medium, homoge-
nized, and extracted; after clarification, the extracts were
FIG. 3. Bioassays of endogenous retinoid content in Day 5.5, 8.5,
and 10 chick embryo tissues and organs. Approximately 100–200
mg of brain, liver, cartilage (metaphyseal–diaphyseal cartilaginous
portion of humerus), and perichondrial tissues from each age group
was extracted in 1 ml of complete culture medium, and the
resulting tissue extracts were added to semiconfluent monolayer
multiwell cultures of F9 retinoid-responsive b-galactosidase re-
porter cells for 16 h; as controls, companion wells received mock-
extracted culture medium (L) or medium containing 3 nM all-
trans-RA (M). Wells were then processed for development of
b-galactosidase activity using X-Gal as a substrate.added to semiconfluent cultures of reporter F9 cells grown
in 12-well plates. Cultures were reincubated for 24 h and
s of reproduction in any form reserved.
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b-galactosidase activity. Negative control wells received
mock-extracted fresh complete medium; positive control
wells received fresh medium containing known amounts of
all-trans-RA.
We found that the cartilaginous tissues contained retin-
oids and did so at each stage of development examined (Figs.
3C, 3F, and 3J). The amounts of retinoids in cartilage tissue
extracts were much lower than those in liver (Figs. 3B, 3E,
and 3I), eye, and skin (not shown) as was expected on the
basis of the large quantities of retinoids present in these
organs (Blaner and Olson, 1994), but were higher than those
FIG. 4. Effects of retinoid antagonist treatment on humerus
development. A bead presoaked in a solution of 3.5 mM Ro 41-5253
was implanted in the vicinity of the humerus (h) anlagen in stage
22 chick embryos (B); as control, humerus anlagen present in
contralateral wing bud was implanted with a control bead contain-
ing vehicle alone (A). Embryos were reincubated until Day 10 and
their wings were examined by macroscopy. Note that antagonist
treatment caused a marked reduction of humerus length (B) com-
pared to control humerus (A), but no changes were appreciable in
radius (r) and ulna (u). Arrowhead points to the implanted bead
visible in control wing.present in brain extracts (Figs. 3A, 3D, and 3H). Strikingly,
we also found that perichondrial tissues displayed ex-
t
Copyright © 1999 by Academic Press. All rightremely large amounts of retinoids (Figs. 3G and 3K).
egative and positive controls gave predictable results; F9
ells receiving vehicle alone (95% ethanol) were totally
egative (Fig. 3L), while cells treated with 3 nM all-
rans-RA were quite positive (Fig. 3M). Our findings that
etinoids are present in limb cartilaginous elements and
hat larger amounts occur in surrounding perichondrial
issues are in excellent agreement with a recent study with
ransgenic mouse embryos in which an RARE/b-
alactosidase reporter gene construct was used to depict
ndogenous retinoids (von Schroeder and Heersche, 1998).
Retinoid Antagonists Derange Skeletal
Development in Vivo
Having shown that RAR gene expression changes during
chondrocyte maturation and that the cartilaginous ele-
ments as well as their surrounding perichondrial tissues
contain endogenous retinoids, we carried out experiments
to determine what roles the RARs and their ligands may
play during chondrocyte maturation and skeletogenesis. To
approach this question, we implanted a bead containing
retinoid antagonists in the vicinity of the prospective hu-
meral mesenchymal condensation in stage 21–22 (Day
3–3.5) chick embryos and determined whether humerus
development had been impaired by Day 10 in vivo; this
approach and time frame are reminiscent of those used in
previous studies on the roles of retinoids in limb patterning
(Summerbell, 1983; Tickle and Crawley, 1988). Two retin-
oid antagonists were used and compared. AGN 193109 was
previously shown to inhibit RARa, b, and g equally well,
with IC50 of 16, 7, and 7 nM, respectively (Klein et al., 1996).
o 41-5253 was instead shown to exert antagonistic effects
referentially on RARa with IC50 of 60 nM and to be much
less effective against RARb and RARg (IC50 5 2400 and
3300 nM, respectively) (Apfel et al., 1992; Keidel et al.,
TABLE 1
Dose-Dependent Effects of Retinoid Antagonists
on Humerus Development
Chick embryo
H.H. stage
Treatment/
dose na
% Normal
limbs
% Limbs with
shortened
humerusb
21–22 None 7 100 0 (0/7)
21–22 Ro/3.5 mM 8 75 25 (2/8)
21–22 Ro/3.5 mM 9 33 67 (6/9)
21–22 AGN/3.5 mM 10 60 40 (4/10)
21–22 AGN/3.5 mM 6 0 100 (6/6)c
a Total number of embryos used. Note that control embryos
indicated as “None”) were implanted with a control bead filled
ith vehicle alone.
b Humerus was considered affected if it was at least 25% shorterhan control.
c Two of these embryos had a shortened ulna or radius also.
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382 Koyama et al.1994). A bead containing Ro 41-5253 or AGN 193109 at
concentrations ranging from 3.5 mM to 3.5 mM was placed
in one wing bud; the contralateral wing bud received a bead
containing vehicle alone and served as control.
Both antagonists had striking effects on humerus devel-
opment. The humerus (h) of Day 10 embryos implanted
with a Ro 41-5253-containing bead was about 50% shorter
(Fig. 4B) than control contralateral humerus treated with
FIG. 5. In situ hybridization analysis of the effects of retinoid an
longitudinal sections of humerus from a Day 10 chick embryo w
from contralateral control wing implanted with a vehicle-fil
riboprobes encoding chick RARg (B and F), osteopontin (C an
haracteristic and well-defined epiphyses (ep) and metaphyses (m
nd is undergoing endochondral ossification (A, arrow), is sur
isplays strong expression of RARg in hypertrophic chondrocy
undergoing endochondral ossification (C). In contrast, the diaphy
no detectable expression of RARg (F) and osteopontin (G), but
xpressing osteopontin, (G, arrowheads). Both control and ant
mplanted bead is visible in the lower left side of (F). Bar, 250 mvehicle alone (Fig. 4A) or untreated humerus (not shown).
The effects were highly selective and topographically lim-
d
t
Copyright © 1999 by Academic Press. All rightted to the humerus; no obvious changes in size and/or
hape were observed in the developing radius, ulna, and
igits (Fig. 4 and Table 1). Similar effects were exerted by
GN 193109, but much lower concentrations of this antag-
nist were required to obtain high frequency of humeral
efects (Table 1), possibly because of its ability to antago-
ize every RAR equally well (Klein et al., 1996).
Histological and in situ hyridization analyses of longitu-
nist treatment on gene expression in developing humerus. Serial
implanted with an Ro 41-5253-filled bead at stage 22 (E–H) and
ead (A–D) were processed for hybridization with 35S-labeled
, and Ihh (D and H). Note that the control humerus displays
d a central long diaphysis (di) (A); the diaphysis is hypertrophic
ded by an intramembranous bony collar (A, arrowheads), and
(B, arrows) and osteopontin in posthypertrophic chondrocytes
antagonist-treated humerus (E) is not hypertrophic and displays
urrounded by an intramembranous bony collar (E, arrowhead)
ist-treated humeri display Ihh expression (D and H, arrows).tago
ing
led b
d G)
e) an
roun
tes
sis of
is sinal sections of Day 10 humeri provided further details of
he effects of the antagonists (Figs. 5 and 6). In control
s of reproduction in any form reserved.
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383Retinoids, RARs, and Limb Skeletal Developmenthumeri the epiphyses and metaphyses were well developed
(Fig. 5A), and the diaphysis contained numerous hypertro-
phic chondrocytes expressing RARg (Fig. 5B, arrows) and
type X collagen (Fig. 6A, arrows), displayed a central core
region undergoing replacement by bone and marrow (Fig.
5A, arrow) and strongly expressing osteopontin (Fig. 5C),
and was surrounded by a thin intramembranous bony collar
also expressing osteopontin (Figs. 5A and 5C, arrowheads).
In sharp contrast, the diaphysis of antagonist-treated hu-
meri contained only small-sized chondrocytes expressing
neither RARg (Fig. 5F) nor osteopontin (Fig. 5G) and type X
ollagen (Fig. 6B, arrow), was completely cartilaginous, and
ad not undergone endochondral ossification nor marrow
nvasion (Fig. 5E). Interestingly, however, the diaphysis was
urrounded by a seemingly normal intramembranous bone
ollar that expressed osteopontin (Figs. 5E and 5G, arrow-
eads), and the metaphyseal portions displayed Ihh gene
expression (Fig. 5H, arrrows) as seen in control (Fig. 5D,
arrows). It is also interesting to note that antagonist-treated
humeri often displayed a curvature (Fig. 5E), with the
FIG. 6. In situ hybridization analysis of type X collagen gene expr
bead presoaked in 3.5 mM AGN 193109 was implanted near the
ead. Longitudinal serial sections through control and treated wings
ybridization. Note that the control humerus displays strong type
ore portion undergoing endochondral ossification (A, arrows), bu
ntagonist-treated humerus (B, arrow). Note that no change in type
way from the implanted beads (A and B, arrowheads). Bar, 550 mmconcave side facing the antagonist-filled bead and the con-
vex side facing the opposite side. No such curvature was
Copyright © 1999 by Academic Press. All rightever observed in control humeri implanted with vehicle-
filled bead, suggesting that the curvature in treated speci-
mens was not simply the result of physical presence of the
bead but may reflect biologically relevant mechanisms (see
Discussion). The effects elicited by the antagonists were
limited to the humerus while skeletal elements distant
from the site of bead implantation were totally normal in
both morphology and gene expression, as exemplified by
strong type X collagen gene expression in the ulnae of
control and antagonist-implanted wings (Figs. 6A and 6B,
arrowheads). This reiterated the conclusion above that the
inhibitory effects exerted by the retinoid antagonists were
limited to the site of bead implantation and did not reflect
generalized systemic effects.
In the next set of experiments, we asked whether antag-
onist treatment initiated at later stages of development
would still lead to inhibition of humerus development; if
so, this would correlate well with our bioassay data show-
ing that endogenous retinoids are continuously present in
the cartilaginous tissues and suggesting that retinoids may
n in control (A) and antagonist-treated (B) limb skeletal elements.
erus anlagen at stage 22; control humerus received a vehicle-filled
e prepared on Day 10 of development and were processed for in situ
lagen gene expression in two diaphyseal regions flanking a central
type X collagen gene expression is detectable in the shortened
llagen expression is seen in distal elements, such as ulna, locatedessio
hum
wer
X col
t no
X cobe continuously required for skeletal development. We also
shortened the treatment period so as to minimize the
s of reproduction in any form reserved.
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384 Koyama et al.interval between experimental manipulation and analysis
of the effects. Thus, we implanted single or multiple AGN
193109-filled beads on one side or around the cartilaginous
humerus in Day 5.5 (stage 28) chick embryos and examined
the effects of Day 8.5. We found that humerus development
FIG. 7. In situ hybridization analysis of retinoid antagonist effects
implanted around the cartilaginous humerus of stage 28 (Day 5.5)
14 (I and J) and longitudinal serial sections of humerus were then p
ranscripts are undetectable in Day 8.5 treated humerus (F and G), b
ore abundant at the periphery than at the center of the diaphysis (C
nd treated humerus (D and H). Note also that the antagonist effec
collagen (I, arrow) and low expression of type II collagen (J, arro
FIG. 8. In situ hybridization analysis of type X collagen gene
expression in long bone diaphysis. Serial sections were prepared
throughout the entire Day 8.5 ulna and were processed for in situ
hybridization. A, B and C, D are bright- and dark-field micrographs
of two representative consecutive sections demonstrating that type
X collagen transcripts are clearly restricted to peripheral chondro-
cytes in the diaphysis at this stage (arrowheads) but are undetect-
able in the more central diaphyseal cells. Bar, 75 mm.
Copyright © 1999 by Academic Press. All rightad been inhibited even after such short treatment time
hen implanted with three or four beads (6/7) (Fig. 7); a
ingle bead was not very effective (5/5) (not shown). Com-
ared to their normal counterparts (Figs. 7A–7C), the
ntagonist-treated humeri were shorter, and their cells had
ot advanced to the hypertrophic stage and lacked tran-
cripts encoding RARg and type X collagen (Figs. 7E–7G).
Both control and treated humeri exhibited very strong
expression of type II collagen (Figs. 7D and 7H), indicating
that the antagonist was not exerting unwanted side effects
on cell viability and differentiated functions. These experi-
ments produced two additional interesting data. The first
was that in control Day 8.5 humerus the first type X
collagen-expressing chondrocytes emerged at the periphery
of the diaphysis (Fig. 7C, arrowheads); this is in perfect
agreement with morphological observations above (see Fig.
2I) and was confirmed by in situ hybridization on serial
sections throughout the diaphysis (Figs. 8A–8D, arrow-
heads). The second interesting point was that the
antagonist-treated humeri were morphologically as straight
as the controls and never displayed a curvature (Fig. 7E),
possibly because the antagonist-filled beads had been placed
on both sides of the humeri (see Discussion).
To determine whether the effects of antagonist treatment
were reversible and would dissipate with time and further
) and recovery (I and J). Beads containing 3.5 mM AGN 193109 were
embryos; embryos were reincubated until Day 8.5 (A–H) or Day
sed for in situ hybridization. Note that RARg and type X collagen
resent in control (B and C), and that type X collagen transcripts are
owheads). Type II collagen transcripts are abundant in both control
ve dissipated by Day 14 as indicated by strong expression of type
the diaphysis. Bar in A–H, 300 mm; bar in I and J, 1 mm.(A–H
chick
roces
ut p
, arrdevelopment, embryos implanted with AGN 193109 beads
at stage 28 (Da 5.5) as above were allowed to develop until
s of reproduction in any form reserved.
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385Retinoids, RARs, and Limb Skeletal DevelopmentDays 14 to 18 of embryogenesis and were then processed for
histology and in situ hybridization. Indeed, we found that
lready by Day 14 the antagonist-treated humeri now
ontained hypertrophic chondrocytes in their diaphysis
xhibiting characteristic gene expression patterns, that is,
trong type X collagen and low type II collagen gene
xpression (Figs. 7I and 7J, arrows). In addition, bone and
one marrow progenitor cells had begun to invade the
ypertrophic cartilage (not shown). These morphological
nd gene expression features normally characterize the
umerus around Day 9–9.5 of embryogenesis, indicating
hat development of antagonist-treated humerus had been
elayed by about 5 days but was now resuming its normal
ourse.
Cultured Chondrocytes
In a final set of studies, we determined whether the
antagonists used in the above in vivo experiments are
FIG. 9. Northern blots to determine changes in gene expression in
culture chondrocytes. Immature caudal sternal chondrocytes (A)
and early hypertrophic cephalic sternal chondrocytes (B and C)
were grown for about 2 weeks in culture and were then treated with
the indicated doses of all-trans-RA, Ro 41-5253, or both for 2, 4, or
6 days; companion cultures were left untreated and served as
control (C). Total cellular RNAs were processed for Northern blot
analysis to determine gene expression of type X collagen (A and B)
and alkaline phosphatase (C).indeed able to antagonize the biological effects of natural
retinoids in chondrocytes, as has been shown in other cells
Copyright © 1999 by Academic Press. All rightand tissues (Apfel et al., 1992; Keidel et al., 1994; Klein et
l., 1996). To address this issue, we carried out experiments
n vitro and determined whether the antagonists were able
o block or inhibit the promaturation effects of exogenous
ll-trans-RA on cultures of chick embryo chondrocytes. As
e showed previously, cultures of immature chondrocytes
solated from the caudal resting portion of Day 17–18 chick
mbryo sternum require treatment with all-trans-RA to
evelop into hypertrophic type X collagen-expressing cells;
ikewise, cultures of newly emerged hypertrophic chondro-
ytes isolated from the cephalic portion of Day 17–18 chick
mbryo sternum require all-trans-RA treatment to com-
lete their maturation into posthypertrophic alkaline
hosphatase-rich, mineralizing chondrocytes (Pacifici et al.,
991; Iwamoto et al., 1993b, 1994).
Thus, immature caudal sternal chondrocytes were grown
n standard serum containing cultures for about 2 weeks.
uring this period, the cells actively proliferated and in-
reased moderately in size (about two- to threefold), indi-
ating that they had advanced to a prehypertrophic stage of
aturation (see Pacifici et al., 1991). Cultures were then
reated with all-trans-RA, Ro 41-5253, or both all-trans-RA
nd Ro 41-5253 or were left untreated. Northern blot
nalysis showed that control untreated cultures contained
arely detectable amounts of type X collagen transcripts
Fig. 9A, lane 1); however, cultures treated for 2, 4, or 6 days
ith 50 nM all-trans-RA displayed a marked time-
FIG. 10. Histochemical determination of mineral deposition in
chondrocyte cultures. Confluent 2-week-old multiwell cultures of
cephalic sternal chondrocytes were treated for 6 days with 100, 250,
or 500 nM Ro 41-5253 (B, C, and D), 25 or 50 nM all-trans-RA (E
and I), or both Ro 41-5253 and all-trans-RA (F–H and J–L). One well
was left untreated as control (A). Cultures were all stained with
alizarin red to reveal the mineral. Note that all-trans-RA treatment
induces abundant mineral deposition (E and I) which is effectively
counteracted by cotreatment with Ro 41-5253 (F–H and J–L). No
mineral is detectable in control culture (A) or in cultures treated
with antagonist alone (B–D).
s of reproduction in any form reserved.
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386 Koyama et al.dependent increase in type X collagen transcripts (Fig. 9A,
lanes 2–4). Such increase was significantly, though not
totally, blocked by cotreatment with 500 nM Ro 41-5253
(Fig. 9A, lanes 8–10); treatment with antagonist alone did
not have major effects (Fig. 9A, lanes 5–7). Thus, Ro 41-5253
is able to counteract the up-regulation of an early matura-
tion marker, type X collagen, in cultured prehypertrophic
caudal sternal chondrocytes.
This conclusion was confirmed and extended with cul-
tures of more mature chondrocytes isolated from the ce-
phalic core portion of sternum. Two-week-old control un-
treated cultures displayed the expected hypertrophic cell
phenotype characterized by a large cell diameter (see
Pacifici et al., 1991) and abundant type X collagen mRNA
(Fig. 9B, lane 1). When the cells were treated with 50 nM
all-trans-RA, gene expression of the later maturation
marker alkaline phosphatase was increased dramatically
(Fig. 9C, lanes 2–4), while expression of type X collagen was
essentially eliminated by 6 days of treatment (Fig. 9B, lanes
2–4), in excellent correlation with the fact that alkaline
phosphatase expression is up-regulated and type X collagen
expression is down-regulated in vivo when hypertrophic
chondrocytes advance to their terminal posthypertrophic
mineralizing stage during endochondral ossification (Iyama
et al., 1991; Iwamoto et al., 1994). The opposite responses of
hese two genes to all-trans-RA treatment were counter-
cted by cotreatment with 500 nM Ro 41-5253; thus,
lkaline phosphatase gene expression remained quite low
hile type X collagen gene expression remained fairly
trong (Figs. 9B and 9C, lanes 8–10). Treatment with
ntagonist alone had no major effects (Figs. 9B and 9C, lanes
–7). Similar data were obtained with AGN 193109 (not
hown).
To examine the mineralizing stage of the chondrocyte
aturation process, maturing chondrocytes isolated from
he cephalic core portion of sternum were grown for 2
eeks in 22-mm multiwell plates until confluent and were
hen treated for 6 days with all-trans-RA, both all-trans-RA
nd Ro 41-5253, or Ro 41-5253 alone. All cultures received
lso b-glycerophosphate, a phosphate donor needed for
mineral formation and deposition; mineral was revealed by
staining with alizarin red. Control untreated cultures ex-
hibited no detectable staining (Fig. 10A). In contrast, cul-
tures treated with 25 or 50 nM all-trans-RA contained
abundant alizarin red-stainable mineral (Figs. 10E and 10I).
Increasing amounts of Ro 41-5253 did effectively antago-
nize the promineralization effects of all-trans-RA (Figs.
10F–10H and 10J–10L) such that cultures cotreated with 25
or 50 nM all-trans-RA and 500 nM Ro 41-5253 exhibited
almost no mineralization (Figs. 10H and 10L). Treatment
with Ro 41-5253 alone had no effects (Figs. 10B–10D).
Thus, exogenous all-trans-RA induces changes in gene
expression, cell behavior, and activities in cultured sternal
chondrocytes which are identical to those occurring at the
different stages of chondrocyte maturation in vivo. The
retinoid antagonists used counteract the promaturation
abilities of all-trans-RA.
Copyright © 1999 by Academic Press. All rightDISCUSSION
RARs and Chondrocyte Maturation
The results of our study demonstrate for the first time
that chondrocyte maturation in the cartilaginous skeletal
elements of chick embryo limbs involves marked changes
in RAR gene expression and that the cartilaginous elements
continuously contain endogenous retinoids. We find that
while expression of RARa remains steady and relatively
low and RARb expression is largely confined to perichon-
rial tissues, expression of RARg is markedly and selec-
tively up-regulated in the hypertrophic zone of growth
plate. We have shown that implantation of retinoid
antagonist-containing beads in the vicinity of early humeral
anlagens interferes with humerus development. The
antagonist-treated humeri in Day 8.5 and 10 chick embryos
were significantly shorter than their normal counterparts
and were still entirely cartilaginous; their metaphyseal–
diaphyseal chondrocytes had remained prehypertrophic
Ihh-expressing cells, had failed to up-regulate RARg gene
xpression, had not matured into hypertrophic and posthy-
ertrophic mineralizing chondrocytes, and were not under-
oing replacement by bone and bone marrow cells. To-
ether, these results provide compelling support for our
ypothesis originally based on in vitro studies (Pacifici et
l., 1991; Iwamoto et al., 1993b, 1994; Shapiro et al., 1994)
hat retinoid-dependent and RAR-mediated action is re-
uired for completion of the chondrocyte maturation pro-
ess and for substitution of mineralized hypertrophic carti-
age with endochondral bone. Because antagonist treatment
locked chondrocyte maturation at the prehypertrophic
hh-expressing stage, we conclude that retinoids normally
ct on prehypertrophic chondrocytes to promote their tran-
ition to the hypertrophic stage. The retinoids would most
ikely act on the prehypertrophic cells by means of the
biquitous RARa; in so doing, the retinoids could directly
r indirectly down-regulate Ihh and other traits of the
rehypertrophic stage, up-regulate RARg gene expression
and activate its biological function, and promote the emer-
gence of hypertrophic chondrocytes.
Retinoids and Gene Expression
Our data with cultured caudal and cephalic sternal chon-
drocytes show that the retinoid antagonists used were able
to effectively counteract the promaturation properties of
natural all-trans-RA in chondrocytes, as seen in other
systems (Apfel et al., 1992; Keidel et al., 1994; Klein et al.,
1996). The antagonists appeared to be fully tolerated by the
cells and produced no obvious side effects, as revealed by
the normal appearance of both cultured chondrocytes (not
shown) and in vivo chondrocytes and neighboring mesen-
chymal cells, even when immediately adjacent to the
antagonist-filled beads. It is interesting to note that the
antagonists interfered with both the up-regulation of type X
collagen gene expression in all-trans-RA-treated maturing
caudal sternal chondrocyte cultures and the down-
s of reproduction in any form reserved.
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387Retinoids, RARs, and Limb Skeletal Developmentregulation of this gene in all-trans-RA-treated hypertrophic
cephalic sternal cultures. The data suggest that normal
retinoid signaling is needed by chondrocytes to modulate
expression of type X collagen in a stage-dependent manner
and that retinoid signaling can either up-regulate or down-
regulate expression of a given gene in the same cell type. A
previous study from our laboratories revealed that no ca-
nonical retinoic acid-responsive elements are present in the
59 promoter region of the chick type X collagen gene (Lu
Valle et al., 1993), indicating that retinoid signaling modu-
lates expression of this gene by indirect means. It is inter-
esting to note also that when the cultures were treated with
antagonist alone, there was no appreciable change in the
maturational stage of the cells and their gene expression
patterns. For example, cephalic sternal chondrocytes, even
when treated with 500 nM Ro 41-5253, were not only
morphologically similar to untreated control cells but also
continued to exhibit strong type X collagen gene expres-
sion. Why didn’t the antagonists produce any obvious
phenotypic effect when used alone on cultured cells? A
likely and interesting possibility is that natural retinoids
are needed by developing chondrocytes to advance from one
stage of maturation to the next but are less crucial or not
needed at all by the cells to maintain a given stage of
maturation. Thus, antagonist treatment alone would not be
able to change the stage of maturation of the cells nor
reverse it, though antagonist treatment would be able to
block the all-trans-RA-induced progression from one stage
of cell maturation to the next. Another possibility is that
the cultured cells may have been able to withstand possible
interfering action by the antagonists because of the pres-
ence of counteracting stabilizing factors in serum.
Control of Size and Shape in Skeletal Elements
The most obvious anatomical defects caused by antago-
nist treatments were shortening and bending of the hu-
merus. Interestingly, similar defects were previously ob-
served in double RARa/RARg null mice, in which humerus
s well as radius and ulna were often short and curved
Lohnes et al., 1994), and in chick embryos treated with
itral, an inhibitor of retinoic acid synthesis (Tanaka et al.,
996). Shortening and/or bending was also seen in trans-
enic mice expressing a constitutively active form of RARa
(Cash et al., 1997) or a dominant-negative RARa under the
ontrol of type II collagen promoter (Yamaguchi et al., 1998)
nd in fetuses and young animals treated with teratogenic
oses of all-trans-RA (Shenefelt, 1972; Kochhar, 1973;
ochhar and Aydelotte, 1974; Woodard et al., 1997) or
etinoid agonists (Elmazar et al., 1996). It is clear then that
ny alteration of normal retinoid signaling, be it the result
f diet, pharmacological treatment, or genetic and gene
xpression manipulations, leads to disproportionate and
bnormal growth of skeletal elements. What could be the
ause of skeletal element shortening? Our data reveal that
ne cause, if not the cause, is lack or delay of chondrocyte
ypertrophy in the diaphysis. Indeed, it has long been
Copyright © 1999 by Academic Press. All rightstablished that chondrocyte hypertrophy is the main de-
erminant of long bone elongation, while chondrocyte pro-
iferation and extracellular matrix accumulation have
esser though important roles in skeletal growth (Hunziker,
994; Wilsman et al., 1996). Thus, by inhibiting or delaying
hondrocyte hypertrophy, interference with normal retin-
id signaling by antagonist treatment indirectly caused
umeral shortening.
The observed curvature of skeletal elements merits fur-
her comments. Under normal circumstances, a striking
haracteristic of developing long bones is that they grow in
preferential proximal-to-distal direction and do so in a
erfectly straight fashion. The mechanisms underlying
uch a difficult task have been sought out for decades but
emain fairly unclear (Thorogood, 1983). It is interesting
hat all the above-mentioned manipulations of retinoid
ignaling in chick or mouse embryos lead not only to long
one shortening but also to bending. One implication of
hese findings is that elongation and shape are coordinately
egulated by common and interrelated mechanisms during
ong bone development and that these mechanisms are
etinoid dependent. Our data reveal that in limbs implanted
ith a single antagonist-filled bead, the concave side of the
ent humerus was facing the bead while the convex side
as facing the opposite direction. Because retinoid-filled
eads create a concentration gradient in the surrounding
issues (Eichele et al., 1984; Tickle et al., 1985), the concave
ide of the humerus, by being closer to the bead, had most
ikely been exposed to larger amounts of antagonists while
he convex side, by being further away, had received lower
mounts. This disequilibrium may have created disequilib-
ium in regulatory mechanisms; for example, chondrocytes
ocated in the concave side of the humerus may have
roliferated less or elaborated lower amounts of extracellu-
ar matrix than those in the convex side, causing bending.
his interpretation is sustained by our observation that in
imbs implanted with antagonist-filled beads placed on
pposite sides of the skeletal elements, no bending was
bserved, presumably because such signaling disequilib-
ium was not created or was not as acute.
Cartilage and Perichondrial Tissues
In studying long bone formation, embryologists recog-
nized long ago that the diaphysis forms and is morphologi-
cally defined first with the appearance of a thickened
perichondrium, while metaphyses and epiphyses remain ill
separated from surrounding mesenchymal tissues and be-
come morphologically defined and organized later (Fell,
1925; Crilly, 1972; Wolpert, 1981; Thorogood, 1983). With
further development, this developmental asynchrony be-
tween diaphysis versus metaphysis–epiphysis is main-
tained. Thus, the diaphysis is the first site at which chon-
drocytes mature and become hypertrophic, perichondrium
is replaced by periosteum, an intramembranous bony collar
forms, and invading bone and marrow progenitor cells give
rise to endochondral bone; at the same time, none of these
s of reproduction in any form reserved.
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388 Koyama et al.events is occurring in the metaphyseal and epiphyseal areas
in which the chondrocytes are still immature and a bony
collar does not form (Thorogood, 1983; Pechak et al., 1986;
Gentili et al., 1994; Carlevaro et al., 1997; Koyama et al.,
995, 1996b). For example, we showed previously that the
ransition from perichondrium to periosteum on the lateral
urface of limb skeletal elements along the epiphysis-to-
iaphysis axis involves marked changes in extracellular
atrix composition (Koyama et al., 1996b). A major impli-
ation of these observations is that events occurring in the
artilage tissue must be coordinated spatially and tempo-
ally with those occurring in the surrounding tissues; in
ther words, chondrocytes and surrounding cells must
ommunicate, interact, coordinate, and influence their be-
aviors and actions (Fell, 1925; Thorogood, 1983).
Interest in these issues has been reinvigorated by the
ecent suggestion that Ihh may mediate interactions be-
ween immature prehypertrophic chondrocytes and adja-
ent perichondrial cells; as a result of Ihh action, perichon-
rium would produce parathyroid hormone-related protein
PTHrP) which in turn would inhibit chondrocyte matura-
ion and limit its rates (Vortkamp et al., 1996; Long and
insenmayer, 1998). This proposal is in line with previous
tudies showing that PTH and PTHrP exert negative effects
n chondrocyte maturation (Kato et al., 1990; Iwamoto et
al., 1995; O’Keefe et al., 1997). However, since chondro-
cytes do become hypertrophic eventually, they must pos-
sess positive means or receive positive signals to escape and
overcome the presumed negative action of Ihh and PTHrP.
What could be such positive means and signals, and how
could negative and positive mechanisms operate and be
orchestrated such that chondrocyte maturation and long
bone development are brought to completion?
We propose that retinoids and RARs represent one such
positive mechanism and counterbalance the presumed
negative influences of Ihh and PTHrP. We show here that
retinoids are present in cartilage at each stage analyzed and
that much larger amounts of them are actually present in
surrounding perichondrial tissues; we have also shown that
the first type X collagen-expressing chondrocytes emerge at
the periphery of the diaphysis, that is, the area of cartilage
closest to surrounding perichondrial tissues. Thus, we pro-
pose that as perichondrial tissues undergo a transition from
perichondrium to periosteum and give rise to a bony collar,
they would produce more retinoids or would receive more
retinoids from the liver via developing bone-associated
vascular supply (Pechak et al., 1986). These retinoids would
diffuse into cartilage, enhance the action of cartilage endog-
enous retinoids, interact with RARa, and lead to up-
egulation of RARg. These events would initially render the
eriphery of the diaphysis more conducive to maturation
ompared to the center of the tissue; with time, they would
nvolve the entire diaphyseal population and lead to initia-
ion of endochondral ossification. Among other things, this
odel accounts for our observations that the first matureype X collagen-expressing chondrocytes emerge at the
eriphery of the diaphysis and that antagonist treatment
Copyright © 1999 by Academic Press. All rightlocks chondrocyte maturation at the prehypertrophic Ihh-
xpressing stage while formation of an intramembranous
ony collar itself is unaffected. The model prescribes that
evelopmental events occurring in cartilage and surround-
ng tissues are not only closely coordinated in time and
pace but are also mutually beneficial and interdependent.
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